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Abstract
Ascl1 (Mash1) is a bHLH transcription factor essential for neural differentiation during embryogenesis but its role in adult
neurogenesis is less clear. Here we show that in the adult brain Ascl1 is dynamically expressed during neurogenesis in the
dentate gyrus subgranular zone (SGZ) and more rostral subventricular zone (SVZ). Specifically, we find Ascl1 levels low in
SGZ Type-1 cells and SVZ B cells but increasing as the cells transition to intermediate progenitor stages. In vivo genetic
lineage tracing with a tamoxifen (TAM) inducible Ascl1
CreERT2 knock-in mouse strain shows that Ascl1 lineage cells
continuously generate new neurons over extended periods of time. There is a regionally-specific difference in neuron
generation, with mice given TAM at postnatal day 50 showing new dentate gyrus neurons through 30 days post-TAM, but
showing new olfactory bulb neurons even 180 days post-TAM. These results show that Ascl1 is not restricted to transit
amplifying populations but is also found in a subset of neural stem cells with long-term neurogenic potential in the adult
brain.
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Introduction
Adult neural stem cells generate new neurons in the subgranular
zone (SGZ) of the hippocampal dentate gyrus and the subven-
tricular zone (SVZ) adjacent to the lateral ventricle [1]. Although
Nestin
+/GFAP
+ astrocytic Type-1 cells in the SGZ or B cells in
the SVZ are considered to be ‘slowly dividing’ stem-like cells that
self-renew and generate neurons throughout life [1], the molecular
identity of neural stem cells remains incompletely defined. To
understand how neural stem cells balance their self-renewal and
differentiation in vivo, it is essential to identify intrinsic factors that
define neural stem cell populations.
Transcription factors have central roles in regulating stem cell
dynamics and reprogramming between distinct somatic lineages
[2,3,4]. Ascl1, for example, is essential during embryogenesis for
neural differentiation [5], is homologous to proneural genes in
Drosophila [6], and functions counter to Notch signaling to balance
progenitor and differentiation states [5]. In addition, Ascl1 is a key
factor in reprogramming fibroblasts directly to functional neurons
in vitro [3]. The importance of Ascl1 to embryonic neural
development makes it a strong candidate for playing a role in adult
neurogenesis as well. Indeed, previous studies using a BAC
transgenic strain expressing CreER in Ascl1 cells showed Ascl1
+
cells are largely transit-amplifying progenitors in the SGZ and
SVZ, and become postmitotic neurons within 30 days [7]. Here
we examine more closely the expression of endogenous Ascl1 in
the adult mouse brain and analyze Ascl1 lineage cells utilizing a
new knock-in mouse strain, Ascl1
CreERT2. Our results show that
Ascl1 is present in the neurogenic lineage earlier than previously
reported, and that Ascl1 lineage cells have long-term neurogenic
potential in both the SGZ and SVZ in the adult mouse brain.
These findings have fundamental implications for our understand-
ing of the molecular identity of the neural stem cell in the postnatal
and adult brain.
Results
Ascl1 is present in Type-1 and Type-2a cells in the
dentate gyrus SGZ of adult mice
Although Ascl1 has been suggested to be a key transcription
factor controlling stem cell dynamics [3,4] in vivo expression of
Ascl1 in adult neural stem cell populations has not been
thoroughly characterized. To gain a more precise understanding
of when Ascl1 is expressed during the stages of adult neurogenesis
[14], brain tissue from 8-week old Nestin::GFP mice [13] was
stained for GFP, GFAP, and Ascl1. Ascl1
+ cells were easily
identified in the adult mouse SGZ (Fig. 1A), as were cells that were
categorized as Type-1 (GFAP
+/Nestin::GFP
+ and radial glial
morphology, Fig. 1B) or Type-2 (GFAP
2/Nestin::GFP
+ and
progenitor morphology, Fig. 1B). However, it was also evident
that Ascl1 cells were heterogeneous in their fluorescent intensity,
with some cells expressing high versus low levels of Ascl1
immunoreactivity (Ascl1
High versus Ascl1
Low) (Fig. 1A). Phenotypic
analysis revealed that Ascl1
Low cells were Type-1 and Type-2,
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High cells were Type-2 (Fig. 1A–E, arrow-
heads). Thus, Ascl1 levels generally appear to increase as
progenitors are selected for neuronal differentiation (Fig. 1F), a
pattern opposite to cells with active Notch signaling as recently
reported [15]. This is reminiscent of the Drosophila homologs
Achaete and Scute that function to select the sensory mother cell
from a proneural cluster [16]. Ascl1 may also be expressed in an
oscillatory manner as a Notch pathway component [17], a
possibility that cannot be determined with static images obtained
with immunofluorescence.
These expression data place Ascl1 in the adult dentate gyrus
SGZ in Type-1 cells, a population of cells defined as stem cells
since they maintain the ability to generate new neurons, at least in
young adult mice [18]. However, our previous efforts to determine
the dynamics of Ascl1
+ progenitor cell development defined a
population of cells that transitioned to postmitotic, NeuN
+ cells
within 30 days [7]. As this previous work used a transgenic mouse
containing a BAC with the Ascl1 coding region replaced by
CreER
TM, we reexamined this issue with an Ascl1
CreERT2 knock-in
mouse strain where CreER
T2 replaced endogenous Ascl1 (Fig. 2A)
such that CreER
T2 is restricted to Ascl1 expressing cells (Fig. 3E–
E9). TAM was administered to Ascl1
CreERT2/+;R26R
YFP/YFP mice 6–
7 weeks old, and the Ascl1 lineage was analyzed 7, 30, and 180
days post-TAM, utilizing YFP expression from the Cre reporter
[12]. In the SGZ 7 days post-TAM, 49% of YFP
+ cells were Sox2
+
early progenitors, with a subset of these (12%) presenting Type-1
cell morphology or labeling for GFAP (Fig. 2C–E9). Furthermore,
although Ascl1 itself rarely co-localizes with NeuroD1, 53% of
YFP
+ cells were NeuroD1
+ identifying them as Type-2b or 3/
immature neurons (Fig. 2F–F9), and implying that cells expressing
CreER
T2 7 days prior have transitioned to later stages within the
lineage. 7 days post-TAM no YFP
+ cells co-labeled with NeuN, a
marker of mature neurons (Fig. 2B). However, 30 days post-TAM,
the population continued to mature, such that 26% of YFP
+ cells
were NeuN
+ granule neurons (Fig. 2J–J9). Notably, even after 30
days post-TAM many YFP
+ cells expressed markers of progenitor
cells, with 29% Sox2
+ and 36% NeuroD1
+, and with 16% clearly
showing Type-1 cell morphology and expressing GFAP (Fig. 2G–
I9). This result is in contrast to that seen when marking only Type-
2 cells, which would all have transitioned to NeuN
+ neurons 30
days post-TAM [7].
To determine the fate of the marked cells over longer periods,
we examined brains 180 days post-TAM. Neurogenesis in the
hippocampus declines dramatically between 12 and 34 weeks of
age [19], illustrated here by fewer cells expressing progenitor
markers (NeuroD1, Doublecortin (DCX), and Ki67; Fig. 2O–V).
Notably, there is no obvious loss of Sox2
+ cells, suggesting Sox2
may mark quiescent Type-1 cells that are only rarely dividing in
aged brains. 180 days post-TAM, 65% of Ascl1 lineage cells
marked by YFP were NeuN
+ granule neurons (Fig. 2N–N9).
Strikingly, 25% of the YFP
+ cells continued to express Sox2,
including 10% with Type-1 cell morphology and expression of
GFAP (Fig. 2K–M9). Consistent with the near absence of
NeuroD1 and DCX at this age (,34 weeks old), no YFP
+ cells
co-labeled with these markers (Fig. 2B).
These Ascl1 lineage results combined with localization of Ascl1
in Nestin::GFP
+/GFAP
+ cells in the adult SGZ demonstrate that
Ascl1 is present in a population of cells with persistent neurogenic
potential beyond that expected from a population of transit
amplifying Type-2 cells. Indeed, these findings with Ascl1
CreERT2
are comparable with those found in a similar paradigm with Nestin-
CreER
T2 or Gli1-CreER
T2 which was shown to mark Type-1 stem-
like cells in the adult SGZ [11,20].
Ascl1 marks a population of cells in the adult SVZ that
have long term neurogenic potential
To determine if Ascl1 also defines a population of cells with long
term potential to generate neurons in the SVZ, we examined Ascl1
expression in the SVZ of Nestin::GFP mice and the dynamics of the
adult-generated Ascl1 lineage cells in the SVZ, rostral migratory
stream (RMS), and olfactory bulb in Ascl1
CreERT2/+;R26R
YFP/YFP
mice. As seen in the SGZ (Fig. 1), SVZ Ascl1
+ cells were
heterogeneous in fluorescent intensity, with cells expressing high
versus low levels of Ascl1 immunoreactivity (Fig. 3A–B9, D), with
the putative stem (B cells) and progenitors (C cells) readily defined
by published criteria (B cells GFAP
+/Nestin::GFP
+; C cells
Figure 1. Ascl1 is present in a subpopulation of Type-1 stem cells and Type-2 progenitors in adult hippocampus. (A–D) Ascl1 is weakly
detected in Nestin::GFP
+GFAP
+ Type-1 stem cells (arrowhead) or strongly detected in Nestin::GFP
+GFAP
2 Type-2 progenitors (arrow) in SGZ of adult
Nestin::GFP mice. (E) Percentage of Ascl1
High or Ascl1
Low cells that express the markers Nestin::GFP and GFAP (Type-1) (dark shaded bars) or just the
marker Nestin::GFP (Type-2) (grey shaded bars). 50 Ascl1
+ cells were counted per mouse, n=3 Nestin::GFP mice. (F) Ascl1 is in Type-1 and early Type-2
cells based on a current model of adult hippocampal neurogenesis [14]. Scale bar =20 mm.
doi:10.1371/journal.pone.0018472.g001
Ascl1 in Adult Neurogenic Niches
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18472GFAP
2/Nestin::GFP
+). In contrast to the SGZ, a much greater
proportion of Ascl1
High and Ascl1
Low expressing cells in the SVZ
were C versus B cells. Notably, no Ascl1
High B cells were present in
the RMS, although many were C cells (Fig. 3C–C9, D). Indeed,
the majority of Ascl1 cells were progenitors or C cells (Fig. 3D)
consistent with previous reports [21]. This is also consistent with
conclusions from lineage tracing studies using the BAC Ascl1::C-
reER transgenic mouse which showed 30 days post-TAM all Ascl1
lineage marked cells had differentiated to neurons in the olfactory
bulb [7]. However, the presence of Ascl1 in a subpopulation of
SVZ B cells suggests that Ascl1 may be marking a stem cell
population, or at least a population with long term neurogenic
potential in this region of the adult brain.
To determine the developmental dynamics of these Ascl1 cells
in the adult SVZ, we used the same paradigm as described above
for the hippocampus using the Ascl1
CreERT2/+ knock-in mouse
strain. Adult (P50) Ascl1
CreERT2/+;R26R
YFP/YFP mice were treated
with TAM for 5 consecutive days. At 7 days post-TAM, YFP
+ cells
co-expressing Sox2 or DCX were found in the SVZ or along the
RMS, whereas no cells co-expressing NeuN were detected
(Fig. 3F–H, O–P9, data not shown). At 30 days post-TAM,
YFP
+ cells co-expressed NeuN in the olfactory bulb, demonstrat-
ing labeled cells are migrating and maturing into neurons (Fig. 3I,
R–R9). Notably, many YFP
+ cells in Ascl1
CreERT2/+;R26R
YFP/YFP
mice still remained in the SVZ and RMS and expressed Sox2,
DCX, or the proliferation marker Ki67 30 days or even 180 days
after initial Ascl1 expression (Fig. 3J–N, Q–Q9, S–T9, data not
shown). This result demonstrates that Ascl1 expressing cells in the
adult SVZ are not just transit amplifying neural progenitors, but at
least some of these cells have long-term (180 days) potential to
Figure 2. A subset of Ascl1 lineage cells continue to produce new granule neurons 30 days after initial Ascl1 expression in adult
hippocampus. (A) Targeting strategy for Ascl1
CreERT2/+ knock-in mice. (B) Quantification of the percentage of YFP
+ cells co-labeled with stage-specific
markers in hippocampus of adult Ascl1
CreERT2/+;R26R
YFP/YFP mice 7, 30, or 180 days post-TAM. 150–500 YFP
+ cells per mouse were counted for each
marker, n=2 Ascl1
CreERT2/+;R26R
YFP/YFP mice per time point. (C–F9) 7 days post-TAM YFP
+ cells co-express GFAP (and have Type-1 morphology), Sox2,
or NeuroD1, but not NeuN. (G–J9) 30 days post-TAM YFP
+ cells overlap with NeuN, but also can co-express GFAP or NeuroD1. (K–N9) 180 days post-
TAM a subpopulation of YFP
+ cells are still Type-1 cells by morphology and express GFAP and Sox2, whereas the majority of YFP
+ cells express NeuN
but not NeuroD1. (O–V) Neurogenesis in the SGZ dramatically decreases between 12 weeks and 34 weeks of age as seen in the decrease in DCX (P,T),
NeuroD1 (Q,U) and Ki67 (R,V). Arrowheads indicate the few cells positive for these markers in the 34 week old mice. Notably, Sox2 does not decrease
(O,S) so may label quiescent Type-1 like cells. Scale bars =50 mm (C,G,K), 10 mm (D–F9, H–J9, I–V).
doi:10.1371/journal.pone.0018472.g002
Ascl1 in Adult Neurogenic Niches
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e18472generate neurons, implying they represent a subset of self-
renewing neural stem cells in this region of the brain.
Discussion
Ascl1 is an essential regulator in multiple regions of the
embryonic nervous system in the balance of whether a cell is
maintained as a progenitor or whether it differentiates(for review
see [5]). It has also recently been shown to be a critical component
in the cocktail, along with Pou3f2 and Mytl1, for directly
reprogramming fibroblasts to neurons [3], and it has aberrant
expression in neural tumors such as glioblastoma [22,23]. Given
that Ascl1 is transiently expressed in adult neurogenic niches [7],
defining the cell types in these lineages that express Ascl1 provides
insight into their molecular identity and in the process of adult
neurogenesis. We show here that Ascl1 is present in populations
that continuously generate olfactory bulb neurons from the adult
SVZ. This is seen in the generation of new YFP-labeled neurons
up to 180 days after labeling in the adult brain of Ascl1
CreERT2
mice. In the SGZ, cells from the Ascl1 lineage also generate
neurons over extended periods (30 days) but as the animal ages
and neurogenesis decreases, so does the generation of new neurons
from Ascl1 marked cells. However, there is a persistent population
Figure 3. A subset of Ascl1 lineage cells in adult SVZ have long term self renewing properties in the generation of olfactory bulb
neurons. (A–D) Ascl1 is detected in Nestin::GFP
+GFAP
+ cells (B cells) in the SVZ (A–B9) and in Nestin::GFP
+GFAP
2 C cells in SVZ (A–B9) and RMS (C,C9)
in 8 week old Nestin::GFP transgenic mice. (D) Percentage of Ascl1
High or Ascl1
Low cells that express the markers Nestin::GFP and GFAP (dark shaded
bars) or just Nestin::GFP (grey shaded bars) in the RMS and the SVZ. 25 Ascl1
+ cells per mouse were counted in the RMS; 60 Ascl1
+ cells per mouse in
the SVZ, n=3 Nestin::GFP mice. (E–E9) mRNA in situ with Ascl1 (E) or Cre (E9) probes in the adult SVZ. (F–T9) Immunofluorescence in Ascl1
CreERT2/+;
R26R
YFP/YFP mouse brain sections harvested 7, 30, or 180 days post-TAM demonstrates Ascl1 derived cells along the SVZ-RMS-OB pathway (F–N). 7
days post-TAM most YFP
+ cells were located in the SVZ, or along the RMS (F–H) and express Sox2 (O–O9) or DCX (P–P9). 30 or 180 days post-TAM YFP
+
cells mature into neurons in the granule cell layer or the periglomerular layer of the OB (I, L, R–R9, and data not shown). However, many YFP
+ cells
remain as Sox2
+ or DCX
+ progenitors in the RMS or SVZ (J–K, M–N, Q–Q9, S–T9). Scale bars =50 mm (F–N), 10 mm (O–T9).
doi:10.1371/journal.pone.0018472.g003
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post-TAM. Together these results imply that Ascl1 is present in at
least a subset of self-renewing, neuron-generating cells. This
conclusion is in contrast to our previous fate mapping studies using
a BAC transgenic Ascl1::CreER
TM mouse, where essentially all
lineage marked cells differentiated to mature neurons within 30
days in the SVZ and the SGZ, which suggested that in this
paradigm Ascl1 lineage cells are restricted to the transit amplifying
populations [7]. The Ascl1
CreERT2/+ knock-in mouse used here
more accurately recapitulates the patterns and timing of Ascl1
expression than that seen in the BAC transgenic mouse based on
comparison of Ascl1 and Cre in situ patterns in multiple tissues at
multiple stages in the two mouse strains (Fig. 3E–E9 and data not
shown), and on the detection of Ascl1 lineage cells in the retina,
olfactory epithelium, and lung in the knock-in model not labeled
with the BAC transgenic model (EJK and JEJ, unpublished). While
Ascl1
CreERT2/+ knock-in mice have only one copy of Ascl1 in
contrast to the BAC model, no phenotype in Ascl1 heterozygous
animals has been reported. Results here show the Ascl1
CreERT2/+
line is labeling a population of cells at an earlier stem-like
progenitor stage than was previously appreciated.
Our placement of Ascl1 in a subset of GFAP
+ cells in the SVZ is
consistent with a report by Pastrana et al. who characterized
expression of GFAP and Ascl1 in EGFR
+ cells isolated from adult
mouse SVZ [24]. In this study, EGFR
+ cells defined two
populations, with 37% of ‘‘activated stem cell astrocytes’’
(GFAP
+/EGFR
+) expressing Ascl1 and a greater proportion of
‘‘transit amplifying cells’’ (GFAP
2/EGFR
+) expressing Ascl1 [24].
Notably, this study found that Ascl1 levels were lower in GFAP
+
cells than in GFAP
2 cells. This is consistent with our results, and
supports the conclusion that Ascl1
CreERT2 is marking cells that
endogenously express Ascl1, even at low levels. The ability of the
GFAP
+/EGFR
+ cells to generate neurospheres [24], combined
with the long term potential of Ascl1 lineage cells to generate
olfactory bulb neurons, implies Ascl1 is present in neural stem cells
in the SVZ.
In the SGZ, the Ascl1
CreERT2 marked cells have a more limited
potential to generate neurons than that seen in the SVZ. However,
this limitation may reflect the age-related decrease in SGZ
neurogenesis [19], and our data remain consistent with the ability
of Ascl1 to mark neural stem cells in both the SGZ and SVZ. In our
lineage tracing studies presented here, two population of marked
cells were evident in the mice 180 days post-TAM: dentate gyrus
granule neurons (NeuN
+, presumably integrated into hippocampal
circuitry), and SGZ Type-1 cells (GFAP
+ with radial glial
morphology). Whether these Type-1 YFP
+ cells in 34 week-old
mice have the potential to generate new neurons in response to
stimulation is not known. The TAM-inducible Cre lineage marking
paradigm used here is unable to distinguish whether these
remaining cells are a distinct population in the SGZ that did not
participate in generating the neurons earlier, or whether they are
the same stem cell population that is now quiescent. Nevertheless,
the Ascl1-lineage marked cells retain the ability to generate new
neurons at least for 30 days in the SGZ of the hippocampal dentate
gyrus, implying they also represent a subset of neural stem cells.
Ascl1 function in neural development includes a major role in
the timing of neuronal differentiation in a balance with Notch
signaling. As a member of the proneural subclass of bHLH factors,
emerging models would place low Ascl1 activity at early stages to
give tone to Notch-regulated progenitor maintenance [17].
Additionally, differing Ascl1 levels could result from unequal
distribution of Ascl1 during asymmetric divisions. Once higher
levels of Ascl1 activity are reached, cells are committed to
neuronal differentiation. Demonstrating the role for Ascl1 in
supporting the maintenance of GFAP
+ neural stem-like popula-
tions must await analysis of an Ascl1 conditional knockout. The
expression characteristics of Ascl1 shown here and in Pastrana et
al., combined with our in vivo lineage tracing over time, clearly
place Ascl1 in cells with long-term neurogenic potential in the
adult brain, a population previously believed to be without Ascl1
expression, and may reflect the interplay of Ascl1 with Notch
signaling to regulate the dynamic equilibrium between stem cell
maintenance and differentiation [15,25,26].
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
procedures used were approved by the University of Texas
Southwestern Medical Center Institutional Animal Care and Use
Committee APN 2007-0065. All efforts were made to minimize
suffering.
Ascl1
CreERT2 knock-in mice were generated by replacing the Ascl1
coding region with CreER
T2 [8] and Frt-Neo-Frt cassettes. The
targeting strategy was the same used to generate Ascl1
GFP knock-in
mice [9]. The endogenous ATG was replaced by a short sequence
containing a PacI site and a consensus Kozak site. The correct
targeting event was identified by Southern analysis of EcoRI
digested DNA using 59 and 39 probes. After obtaining germ line
transmission in the Ascl1
CreERT2-Frt-Neo-Frt mice, they were crossed
with FLPe mice [10] to remove the neomycin cassette resulting in
Ascl1
CreERT2 mice.
For PCR genotyping, the following primers were used: 59-AAC
TTT CCT CCG GGG CTC GTT TC-39 (Sense Ascl1 59UTR)
and 59-CGC CTG GCG ATC CCT GAA CAT G-39 (Anti sense
Cre) giving a PCR product of 247 bp. Tamoxifen (TAM)
induction of Cre recombinase was accomplished by intraperito-
neal injection of Ascl1
CreERT2/+;R26R
YFP/YFP postnatal day 50 (P50)
mice with 180 mg/kg/day TAM (Sigma, T55648) in sunflower oil
on five consecutive days. Brains were harvested at the times
specified after TAM and processed as described [7,11]. R26R
YFP
and Nestin::GFP mice have been previously described [12,13].
For immunofluorescence staining, free floating sections or
sections mounted on slides were incubated in the appropriate
dilution of primary antibody in PBS/3% donkey (or goat) serum/
0.2% NP-40 (or 0.2% Triton X-100), followed by appropriate
secondary antibody conjugated with AlexaFluor 488, 568, or 594
(Molecular Probes). Mouse monoclonal antibodies used were:
Ascl1 (1:750, RDI Fitzgerald, 10R-M106B), NeuN (1:1000,
Chemicon, MAB377), GFAP (1:400, Sigma, G3893). Rabbit
polyclonal antibodies used were: GFP (1:500, Molecular Probes,
A6455), GFAP (1:500, DAKO, Z0334), Ki67 (1:500, Neomarker),
Sox2 (1:2000, Millipore). Goat polyclonal antibodies used were:
DCX (1:200, Santa Cruz) and NeuroD1 (1:200, Santa Cruz).
Chick GFP (1:500, Aves Lab) was also used. Confocal imaging was
carried out on a Zeiss LSM510 confocal microscope. Ascl1
+
fluorescence intensity levels were classified as high or low using
ImageJ and setting a threshold of pixel intensity for Ascl1
Low (314–
599 units) and Ascl1
High (.600 units). For cell number counts,
three Nestin::GFP mice were analyzed to place Ascl1
+ progenitors
in the adult neural stem cell lineage. For in vivo genetic tracing
experiments using the Ascl1
CreERT2 knock-in line, at least two
Ascl1
CreERT2/+;R26R
YFP/YFP mice per each harvest time point (7,
30, or 180 days post-TAM) were used. For co-localization data
with each stage-specific marker, 150–500 YFP
+ cells per animal
were counted.
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